Skip to main content

The business and patient case for drug delivery device innovation in biosimilar products

APRIL 2021
Share the article

Manufacturing Chemist covers the latest developments throughout every aspect of the pharmaceutical supply chain, along with detailed technical articles, market analysis, and expert insights from those shaping the industry on a daily basis. With its global perspective and deep dives into important topics, it is a must-read for anyone working in or around the worldwide pharmaceutical marketplace. Its audience includes those interested in processing and packaging for both the pharmaceutical and cosmetics sectors, the pharmaceutical raw materials field, and the wider chemical industries.

In their April issue, our Regulatory Affairs Manager Darren Mansell takes a closer look at the business and patient case for innovation in drug delivery for biosimilar products. As more patients are administering treatments themselves, the design of drug delivery devices can be essential for long-term patient retention. Learn more on pages 18-19 at the link below.

Get in touch

* Field is required.